These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 25012937)

  • 21. Chromatin modifications remodel cardiac gene expression.
    Mathiyalagan P; Keating ST; Du XJ; El-Osta A
    Cardiovasc Res; 2014 Jul; 103(1):7-16. PubMed ID: 24812277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Valproic Acid Limits Pancreatic Recovery after Pancreatitis by Inhibiting Histone Deacetylases and Preventing Acinar Redifferentiation Programs.
    Eisses JF; Criscimanna A; Dionise ZR; Orabi AI; Javed TA; Sarwar S; Jin S; Zhou L; Singh S; Poddar M; Davis AW; Tosun AB; Ozolek JA; Lowe ME; Monga SP; Rohde GK; Esni F; Husain SZ
    Am J Pathol; 2015 Dec; 185(12):3304-15. PubMed ID: 26476347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HDAC inhibition delays cell cycle progression of human bladder cancer cells in vitro.
    Vallo S; Xi W; Hudak L; Juengel E; Tsaur I; Wiesner C; Haferkamp A; Blaheta RA
    Anticancer Drugs; 2011 Nov; 22(10):1002-9. PubMed ID: 21822119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histone deacetylase inhibition alters histone methylation associated with heat shock protein 70 promoter modifications in astrocytes and neurons.
    Marinova Z; Leng Y; Leeds P; Chuang DM
    Neuropharmacology; 2011 Jun; 60(7-8):1109-15. PubMed ID: 20888352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Valproate recovers the inhibitory effect of dexamethasone on the proliferation of the adult dentate gyrus-derived neural precursor cells via GSK-3β and β-catenin pathway.
    Boku S; Nakagawa S; Masuda T; Nishikawa H; Kato A; Takamura N; Omiya Y; Kitaichi Y; Inoue T; Kusumi I
    Eur J Pharmacol; 2014 Jan; 723():425-30. PubMed ID: 24211784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histone deacetylases are required for amphibian tail and limb regeneration but not development.
    Taylor AJ; Beck CW
    Mech Dev; 2012; 129(9-12):208-18. PubMed ID: 22947425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of histone deacetylases.
    Huang Y; Shaw PG; Davidson NE
    Methods Mol Biol; 2011; 791():297-311. PubMed ID: 21913088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In Vitro Effect of the Histone Deacetylase Inhibitor Valproic Acid on Viability and Apoptosis of the PLC/PRF5 Human Hepatocellular Carcinoma Cell Line.
    Sanaei M; Kavoosi F; Roustazadeh A; Shahsavani H
    Asian Pac J Cancer Prev; 2018 Sep; 19(9):2507-2510. PubMed ID: 30256044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histone deacetylase inhibitor significantly improved the cloning efficiency of porcine somatic cell nuclear transfer embryos.
    Huang Y; Tang X; Xie W; Zhou Y; Li D; Yao C; Zhou Y; Zhu J; Lai L; Ouyang H; Pang D
    Cell Reprogram; 2011 Dec; 13(6):513-20. PubMed ID: 22029418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Troglitazone inhibits histone deacetylase activity in breast cancer cells.
    Davies GF; Ross AR; Arnason TG; Juurlink BH; Harkness TA
    Cancer Lett; 2010 Feb; 288(2):236-50. PubMed ID: 19699029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Valproic acid-mediated neuroprotection in intracerebral hemorrhage via histone deacetylase inhibition and transcriptional activation.
    Sinn DI; Kim SJ; Chu K; Jung KH; Lee ST; Song EC; Kim JM; Park DK; Kun Lee S; Kim M; Roh JK
    Neurobiol Dis; 2007 May; 26(2):464-72. PubMed ID: 17398106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adenomatous polyposis coli determines sensitivity to histone deacetylase inhibitor-induced apoptosis in colon cancer cells.
    Huang X; Guo B
    Cancer Res; 2006 Sep; 66(18):9245-51. PubMed ID: 16982769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological Histone Deacetylation Distinguishes Transcriptional Regulators.
    Rafehi H; Karagiannis TC; El-Osta A
    Curr Top Med Chem; 2017; 17(14):1611-1622. PubMed ID: 27823568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease?
    Harrison IF; Dexter DT
    Pharmacol Ther; 2013 Oct; 140(1):34-52. PubMed ID: 23711791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Valproic acid shows a potent antitumor effect with alteration of DNA methylation in neuroblastoma.
    Gu S; Tian Y; Chlenski A; Salwen HR; Lu Z; Raj JU; Yang Q
    Anticancer Drugs; 2012 Nov; 23(10):1054-66. PubMed ID: 22863973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Valproic acid-mediated neuroprotection in retinal ischemia injury via histone deacetylase inhibition and transcriptional activation.
    Zhang Z; Qin X; Tong N; Zhao X; Gong Y; Shi Y; Wu X
    Exp Eye Res; 2012 Jan; 94(1):98-108. PubMed ID: 22143029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HDAC inhibitors induce global changes in histone lysine and arginine methylation and alter expression of lysine demethylases.
    Lillico R; Sobral MG; Stesco N; Lakowski TM
    J Proteomics; 2016 Feb; 133():125-133. PubMed ID: 26721445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A proapoptotic effect of valproic acid on progenitors of embryonic stem cell-derived glutamatergic neurons.
    Fujiki R; Sato A; Fujitani M; Yamashita T
    Cell Death Dis; 2013 Jun; 4(6):e677. PubMed ID: 23788034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Docking Studies of Glutamine Valproic Acid Derivative (S)-5- amino-2-(heptan-4-ylamino)-5-oxopentanoic Acid (Gln-VPA) on HDAC8 with Biological Evaluation in HeLa Cells.
    Martínez-Ramos F; Luna-Palencia GR; Vásquez-Moctezuma I; Méndez-Luna D; Fragoso-Vázquez MJ; Trujillo-Ferrara J; Meraz-Ríos MA; Mendieta-Wejebe JE; Correa-Basurto J
    Anticancer Agents Med Chem; 2016; 16(11):1485-1490. PubMed ID: 26845132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The teratogenic potencies of valproic acid derivatives and their effects on biological end-points are related to changes in histone deacetylase and Erk1/2 activities.
    Gotfryd K; Hansen M; Kawa A; Ellerbeck U; Nau H; Berezin V; Bock E; Walmod PS
    Basic Clin Pharmacol Toxicol; 2011 Sep; 109(3):164-74. PubMed ID: 21439023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.